XML 30 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Oct. 02, 2020
Sep. 27, 2019
Sep. 28, 2018
Cash flows from operating activities:      
Net (loss) income $ (461,435) $ 448,466 $ 568,440
Adjustments to reconcile net (loss) income to net cash provided by operating activities:      
Depreciation and amortization 595,195 592,573 596,182
Goodwill impairment and asset write-downs 283,743 0 0
Deferred income taxes (134,048) 40,503 (104,289)
Share-based compensation expense 30,339 55,280 88,276
Net gain on sale of Healthcare Technologies 0 (139,165) 0
Changes in operating assets and liabilities:      
Accounts Receivable 362,708 (78,771) (45,891)
Inventories (25,675) (49,732) (40,187)
Prepayments and Other Current Assets (86,444) (37,854) 42,450
Accounts Payable (342,069) 17,680 26,658
Accrued Expenses (143,640) 193,532 (111,386)
Payments made to clients on contracts (69,575) (40,073) 0
Changes in other noncurrent liabilities 92,782 18,904 1,576
Changes in other assets 66,650 (41,436) (2,225)
Other operating activities 8,151 4,320 32,271
Net cash provided by operating activities 176,682 984,227 1,051,875
Cash flows from investing activities:      
Purchases of property and equipment and other (418,508) (503,090) (628,604)
Disposals of property and equipment 54,074 17,871 10,491
Proceeds from divestitures 0 293,711 0
Acquisition of certain businesses, net of cash acquired      
Working capital other than cash acquired (3,081) 10,634 37,985
Property and equipment (1,264) (3,320) (283,447)
Additions to goodwill, other intangible assets and other assets, net (17,856) (52,177) (1,994,822)
Proceeds from governmental agencies related to property and equipment 23,550 23,025 0
Other investing activities 1,965 3,825 (6,879)
Net cash used in investing activities (361,120) (209,521) (2,865,276)
Cash flows from financing activities:      
Proceeds from long-term borrowings 3,239,772 77,630 3,177,313
Payments of long-term borrowings (1,000,463) (654,560) (973,689)
Net change in funding under the Receivables Facility 315,600 0 (254,200)
Payments of dividends (110,893) (108,439) (103,115)
Proceeds from issuance of common stock 90,022 39,087 21,507
Repurchase of common stock (6,540) (50,000) (24,410)
Other financing activities (89,976) (38,610) (49,253)
Net cash provided by (used in) financing activities 2,437,522 (734,892) 1,794,153
Effect of foreign exchange rates on cash and cash equivalents 9,461 (8,196) (4,524)
Increase (decrease) in cash and cash equivalents 2,262,545 31,618 (23,772)
Cash and cash equivalents, beginning of period 246,643 215,025 238,797
Cash and cash equivalents, end of period $ 2,509,188 $ 246,643 $ 215,025